Remetinostat is a hydroxamic acid-based inhibitor of histone deacetylase enzymes. It is under development for the treatment of cutaneous T-cell lymphoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 106 | |
4 mg | In stock | $ 201 | |
8 mg | In stock | $ 288 | |
20 mg | In stock | $ 564 | |
40 mg | In stock | $ 846 |
Description | Remetinostat is a hydroxamic acid-based inhibitor of histone deacetylase enzymes. It is under development for the treatment of cutaneous T-cell lymphoma. |
Synonyms | SHP-141 |
CAS No. | 946150-57-8 |
Chemical Formula | C16H21NO6 |
Molecular Weight | 323.345 |
Solubility | DMSO: 150 mg/mL (463.91 mM), Need ultrasonic |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom